Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Sangal Papers
Join Channel
Consolidated Standalone

Sangal Papers

₹200.4 0 | 0%

Market Cap ₹26 Cr.

Stock P/E 9.3

P/B 0.6

Current Price ₹200.4

Book Value ₹ 341.6

Face Value 10

52W High ₹325

Dividend Yield 0%

52W Low ₹ 151.1

Edit Ratio

Sangal Papers Research see more...

Overview Inc. Year: 1980Industry: Paper & Paper Products

Sangal Papers Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Sangal Papers Quarterly Results

#(Fig in Cr.) Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 60 50 47 46 49 43 51 40 47 48
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 60 50 47 46 49 43 51 40 47 48
Total Expenditure 58 47 46 43 47 41 48 39 45 46
Operating Profit 2 2 0 3 2 2 4 1 2 2
Interest 1 1 1 1 1 1 1 1 1 1
Depreciation 0 0 0 0 0 0 1 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 -1 2 1 1 2 0 1 1
Provision for Tax 0 0 -0 0 0 0 1 -0 0 0
Profit After Tax 1 1 -0 1 1 1 2 0 0 1
Adjustments 0 0 -0 -0 0 0 0 -0 0 0
Profit After Adjustments 1 1 -0 1 1 1 2 0 0 1
Adjusted Earnings Per Share 4.8 7 -3.5 8.8 6.6 5.1 11.9 1.3 3.3 6.2

Sangal Papers Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 93 94 104 120 148 126 106 155 226 190 180 186
Other Income 0 0 0 1 1 1 0 1 2 1 1 0
Total Income 93 95 105 120 149 127 106 156 228 191 181 186
Total Expenditure 88 89 99 114 139 121 103 150 220 184 172 178
Operating Profit 6 6 6 6 10 5 4 5 9 8 9 9
Interest 2 2 2 2 2 2 2 2 2 3 3 4
Depreciation 1 1 1 1 1 1 1 1 2 2 2 1
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 2 3 4 7 2 1 2 5 3 4 4
Provision for Tax 1 1 1 1 1 0 0 0 1 1 1 1
Profit After Tax 1 2 2 3 6 2 1 2 3 2 3 3
Adjustments 0 0 0 0 0 0 0 0 -0 -0 -0 0
Profit After Adjustments 1 2 2 3 6 2 1 2 3 2 3 3
Adjusted Earnings Per Share 10.8 12.7 13.1 19.9 46.9 13.8 5 12.6 25.9 18.9 21.6 22.7

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -5% 5% 7% 7%
Operating Profit CAGR 13% 22% 12% 4%
PAT CAGR 50% 14% 8% 12%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -26% -4% 20% 16%
ROE Average 7% 7% 6% 8%
ROCE Average 10% 10% 8% 11%

Sangal Papers Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 19 21 23 25 31 33 34 36 39 42 44
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 7 7 6 6 7 6 7 9 10 10 9
Other Non-Current Liabilities 4 4 5 4 4 4 4 4 5 5 6
Total Current Liabilities 28 26 20 28 26 25 26 26 37 33 33
Total Liabilities 58 57 53 63 68 69 71 74 90 90 92
Fixed Assets 20 21 21 25 28 30 32 30 36 35 40
Other Non-Current Assets 0 0 2 0 1 1 0 2 0 4 0
Total Current Assets 38 35 30 38 39 38 39 42 53 51 53
Total Assets 58 57 53 63 68 69 71 74 90 90 92

Sangal Papers Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 2 1 1 1 0 0 0 0 0 1 1
Cash Flow from Operating Activities 1 4 9 2 8 3 7 1 4 4 6
Cash Flow from Investing Activities -3 -2 -2 0 -5 -2 -3 -0 -7 -3 -4
Cash Flow from Financing Activities 1 -2 -6 -0 -3 -0 -3 -1 4 -1 -2
Net Cash Inflow / Outflow -2 0 0 2 0 -0 -0 -0 1 0 -0
Closing Cash & Cash Equivalent 1 1 1 3 0 0 0 0 1 1 1

Sangal Papers Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 10.84 12.68 13.07 19.9 46.94 13.79 5 12.55 25.9 18.9 21.62
CEPS(Rs) 15.99 19.02 20.21 27.61 55.95 23.68 15.43 23.51 38.06 32.04 36.29
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 143.41 156.09 169.25 189.26 236.49 250.04 257.54 270.04 295.62 314.16 335.48
Core EBITDA Margin(%) 5.55 5.68 5.03 4.68 6.15 3.59 3.12 2.93 2.92 3.56 4.36
EBIT Margin(%) 5.1 5.02 4.44 4.37 6.13 3.22 2.27 2.43 3.11 3.17 3.65
Pre Tax Margin(%) 2.52 2.56 2.45 3.01 4.94 1.51 0.72 1.37 2.12 1.82 2.22
PAT Margin (%) 1.49 1.71 1.6 2.16 4.14 1.43 0.62 1.06 1.5 1.3 1.57
Cash Profit Margin (%) 2.2 2.56 2.47 3 4.93 2.46 1.9 1.98 2.2 2.2 2.63
ROA(%) 2.52 2.88 3.11 4.47 9.34 2.63 0.94 2.26 4.12 2.75 3.1
ROE(%) 7.86 8.47 8.04 11.1 22.05 5.67 1.97 4.76 9.16 6.2 6.65
ROCE(%) 11.74 11.44 11.46 12.39 19.46 7.93 4.56 7.04 11.91 9.22 9.52
Receivable days 69.1 74.7 65.35 60.61 54.31 65.38 81.26 57.73 42.91 51.24 52.46
Inventory Days 63.16 55.59 39.95 36.17 36.66 42.41 46.25 35.2 31.3 43.24 46.36
Payable days 66.26 60.43 40.59 42.93 51.38 57.57 67.77 49.82 40.81 54.23 47.84
PER(x) 4.24 4.25 8.2 4.69 3.13 3.54 12.62 7.07 4.95 9.89 8.87
Price/Book(x) 0.32 0.35 0.63 0.49 0.62 0.2 0.24 0.33 0.43 0.59 0.57
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.31 0.3 0.3 0.26 0.25 0.21 0.25 0.2 0.18 0.26 0.28
EV/Core EBITDA(x) 5.31 5 5.49 5.04 3.6 4.96 7.1 5.9 4.72 6.38 5.99
Net Sales Growth(%) -6.93 1.27 10.48 14.89 23.79 -15.21 -15.73 46.34 45.88 -15.82 -5.29
EBIT Growth(%) -2.94 0.49 -2.26 10.62 72.56 -55.49 -40.51 56.32 86.9 -14.03 8.97
PAT Growth(%) -9.69 16.92 3.11 52.23 135.86 -70.62 -63.78 151.33 106.31 -27.03 14.38
EPS Growth(%) -9.69 16.92 3.11 52.23 135.86 -70.62 -63.78 151.33 106.31 -27.03 14.38
Debt/Equity(x) 1.27 1.08 0.83 0.8 0.58 0.62 0.56 0.54 0.65 0.65 0.61
Current Ratio(x) 1.35 1.37 1.53 1.35 1.52 1.52 1.51 1.62 1.46 1.54 1.6
Quick Ratio(x) 0.78 0.84 1.09 0.86 0.92 0.98 1 0.99 0.85 0.85 0.9
Interest Cover(x) 1.98 2.04 2.22 3.22 5.16 1.89 1.47 2.29 3.15 2.35 2.55
Total Debt/Mcap(x) 3.97 3.14 1.32 1.62 0.94 3.19 2.27 1.65 1.49 1.08 1.07

Sangal Papers Shareholding Pattern

# Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 39.48 39.48 39.48 39.48 39.48 39.48 39.48 39.48 39.48 39.48
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 60.52 60.52 60.52 60.52 60.52 60.52 60.52 60.52 60.52 60.52
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at 0.6 times its book value
  • Debtor days have improved from 54.23 to 47.84days.
  • Company has reduced debt.

Cons

  • Promoter holding is low: 39.48%.
  • Company has a low return on equity of 7% over the last 3 years.
  • The company has delivered a poor profit growth of 8% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Sangal Papers News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!